Delivery Order SPE2DR25D2213-SPE2DR26F6DBY
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 27, 2025, for Adderall XR 10 mg capsules (100 count) with a ceiling value of $1,003.46. The contract is firm fixed-price with no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,862.68. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,508.14. This non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,059.74. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The ultimate completion date for this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,015.70. This is a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 20 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,586.45 under a firm fixed-price delivery order arrangement, with an ultimate completion date of December 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Adderall XR 30 mg capsules (100 count) with a ceiling value of $2,144.00 and a completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $1,149.20. This non-set-aside award is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,415.15. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- SPE2DR25D2213Indefinite Delivery Contract
- SPE2DR25D2213-SPE2DR26F6DBYDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 16, 2025, for Adderall XR 30 mg capsules (quantity: 100s) with a ceiling value of $1,113.87. This firm fixed price contract, which is a child order under a larger indefinite delivery contract (IDC), carries an ultimate completion date of December 17, 2025. The award was competitively awarded with no set-aside designation and involves performance at the company's Conshohocken facility. This delivery order is part of AmerisourceBergen Drug Corp's broader engagement with the DLA Troop Support Medical, which includes a substantial prime IDC valued at $999,999,999.00 running through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems, enabling the supply of a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded contracts demonstrates its capability to meet federal medical procurement requirements at varying order values and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/15/25 |